OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

MYCN-driven fatty acid uptake is a metabolic vulnerability in neuroblastoma
Ling Tao, Mahmoud A. Mohammad, Giorgio Milazzo, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

UCHL1 is a potential molecular indicator and therapeutic target for neuroendocrine carcinomas
Shiqin Liu, Timothy Chai, Fernando Jose Garcia-Marques, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 2, pp. 101381-101381
Open Access | Times Cited: 16

MYCN Impact on High-Risk Neuroblastoma: From Diagnosis and Prognosis to Targeted Treatment
Damiano Bartolucci, Luca Montemurro, Salvatore Raieli, et al.
Cancers (2022) Vol. 14, Iss. 18, pp. 4421-4421
Open Access | Times Cited: 31

A Mammalian Conserved Circular RNA CircLARP1B Regulates Hepatocellular Carcinoma Metastasis and Lipid Metabolism
Jingxin Li, Xiaolin Wang, Liang Shi, et al.
Advanced Science (2023) Vol. 11, Iss. 2
Open Access | Times Cited: 17

MYCN and Metabolic Reprogramming in Neuroblastoma
Mohit Bansal, Anamika Gupta, Han‐Fei Ding
Cancers (2022) Vol. 14, Iss. 17, pp. 4113-4113
Open Access | Times Cited: 23

Theoretical Framework and Emerging Challenges of Lipid Metabolism in Cancer
Qiuying Gu, Yuan Wang, Ping Yi, et al.
Seminars in Cancer Biology (2024)
Open Access | Times Cited: 5

A high-throughput screening platform to identify MYCN expression inhibitors for liver cancer therapy
Yali Xu, Hricha Mishra, Yutaka Furutani, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access

Chewing the fat: How lipidomics is changing our understanding of human health and disease in 2022
Caroline Géhin, Stephen J. Fowler, Drupad K. Trivedi
Analytical Science Advances (2023) Vol. 4, Iss. 3-4, pp. 104-131
Open Access | Times Cited: 10

Chronic β3‐AR stimulation activates distinct thermogenic mechanisms in brown and white adipose tissue and improves systemic metabolism in aged mice
Duraipandy Natarajan, Bhuvana Plakkot, Kritika Tiwari, et al.
Aging Cell (2024) Vol. 23, Iss. 12
Open Access | Times Cited: 3

Identification of ferroptosis‐related genes in type 2 diabetes mellitus based on machine learning
Sen Wang, Yongpan Lu, Tingting Chi, et al.
Immunity Inflammation and Disease (2023) Vol. 11, Iss. 10
Open Access | Times Cited: 8

Metabolic protein kinase signalling in neuroblastoma
William J. Smiles, Luca Catalano, Victoria E. Stefan, et al.
Molecular Metabolism (2023) Vol. 75, pp. 101771-101771
Open Access | Times Cited: 6

Unsaturated Fatty Acid Synthesis Is Associated with Worse Survival and Is Differentially Regulated by MYCN and Tumor Suppressor microRNAs in Neuroblastoma
Dennis A. Sheeter, Secilia Garza, Hui Gyu Park, et al.
Cancers (2024) Vol. 16, Iss. 8, pp. 1590-1590
Open Access | Times Cited: 2

Defining neuroblastoma: from origin to precision medicine
Lourdes Sainero‐Alcolado, Tomas Sjöberg Bexelius, Giuseppe Santopolo, et al.
Neuro-Oncology (2024) Vol. 26, Iss. 12, pp. 2174-2192
Open Access | Times Cited: 2

Metabolic reprogramming of cancer cells by JMJD6-mediated pre-mRNA splicing associated with therapeutic response to splicing inhibitor
Carolyn M. Jablonowski, Waise Quarni, Shivendra V. Singh, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 6

Lipid Metabolic Reprogramming in Embryonal Neoplasms with MYCN Amplification
Jyotirmayee Talapatra, Mamatha M. Reddy
Cancers (2023) Vol. 15, Iss. 7, pp. 2144-2144
Open Access | Times Cited: 5

Triple Therapy with Metformin, Ketogenic Diet, and Metronomic Cyclophosphamide Reduced Tumor Growth in MYCN-Amplified Neuroblastoma Xenografts
Luca Catalano, Sepideh Aminzadeh-Gohari, Daniela D. Weber, et al.
Metabolites (2023) Vol. 13, Iss. 8, pp. 910-910
Open Access | Times Cited: 5

MYCN Amplifications and Metabolic Rewiring in Neuroblastoma
Marialena Pouliou, Marianna A. Koutsi, Lydia Champezou, et al.
Cancers (2023) Vol. 15, Iss. 19, pp. 4803-4803
Open Access | Times Cited: 5

Unique lipid composition maintained by extracellular blockade leads to prooncogenicity
Kai Kudo, Ryo Yanagiya, Masanori Hasegawa, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 1

Identification of a fatty acid metabolism-related gene signature to predict prognosis in stomach adenocarcinoma
Lei Liu, Jing Sun, Changqing Zhong, et al.
Aging (2024) Vol. 16, Iss. 10, pp. 8552-8571
Open Access | Times Cited: 1

The metabolic benefits of thermogenic stimulation are preserved in aging
Duraipandy Natarajan, Bhuvana Plakkot, Kritika Tiwari, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1

Regulation of cancer cell lipid metabolism and oxidative phosphorylation by microenvironmental acidosis
Michala G. Rolver, Marc Severin, Stine F. Pedersen
AJP Cell Physiology (2024) Vol. 327, Iss. 4, pp. C869-C883
Closed Access | Times Cited: 1

Excessive lipid production shapes glioma tumor microenvironment
Haitham H. Maraqah, John Paul Aboubechara, Mones Abu‐Asab, et al.
Ultrastructural Pathology (2024) Vol. 48, Iss. 5, pp. 367-377
Open Access | Times Cited: 1

Joint metabolomics and transcriptomics analysis systematically reveal the impact of MYCN in neuroblastoma
Bang Du, Yingyu Zhang, Pin Zhang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1

Metabolic targeting of neuroblastoma, an update.
Leila Jahangiri
Cancer Letters (2024), pp. 217393-217393
Open Access | Times Cited: 1

Prognostic significance and immune landscape of a fatty acid metabolism-related gene signature in colon adenocarcinoma
Xia Liu, Xisheng Fang, Lin Lu, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 6

Page 1 - Next Page

Scroll to top